EFFICIENCY OF ADDING AN IMMUNE RESTORATIVE AGENT TO THE CURRENT TREATMENT REGIMENS OF PULMONARYTUBERCULOSIS PATIENTS WITH DRUG RESISTANCE
The single prospective study was conducted in order to assess clinical efficiency of adding the immune restorative agent of deoxyribonucleat sodium (Derinat) to the current chemotherapy regimens of 102 patients (new cases or relapses) with destructive pulmonary tuberculosis with multiple or extensiv...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
NEW TERRA Publishing House
2018-01-01
|
| Series: | Tuberkulez i Bolezni Lëgkih |
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/1070 |